A federal appeals court on Thursday rejected Eli Lilly's appeal of an $183.7 million judgment won by a whistleblowing lawyer ...

Eli Lilly's approved blood cancer therapy Jaypirca helped delay progression of the disease in previously untreated patients ...

Novo Nordisk, the maker of weight loss drug Wegovy, will lay off about 9,000 people as it grapples with rising competition in ...

Drugmaker Eli Lilly said on Tuesday it is launching an artificial intelligence and machine learning platform that provides ...

In recent years, Lilly's top line has been growing at a much faster pace thanks to its already approved GLP-1 injections, ...

Eli Lilly (LLY) stock in focus as a federal appeals court upholds a lower court ruling which ordered the company to pay ...

Building in Houston expands Eli Lilly’s United States production at a time when its competitor, Novo Nordisk, maker of ...

Big Pharma faces tariff risks, patent cliffs, and regulatory pressure, but innovation and strong pipelines keep Eli Lilly, ...

Office cluster with Takeda HQ refinances for $1.3B Lilly’s latest $1B+ obesity deal is with Boston biotech Lilly’s latest ...

Eli Lilly's new TuneLab platform gives biotech firms AI-powered drug discovery tools using $1 billion of proprietary research ...

Takeda names Rhonda Pacheco as U.S. Business Unit President, bringing expertise from Eli Lilly. Read more here.

A $193 million award against Eli Lilly and Co. in a False Claims Act suit alleging Medicaid fraud will stand, the Seventh Circuit ruled Thursday.